Armistice Capital »

Fibrogen shares owned by Armistice Capital

Quarter-by-quarter ownership of Fibrogen (FGEN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Fibrogen

Tip: Access up to 7 years of quarterly data

All positions including Fibrogen held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrogen by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.6M 378k 12.25

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Fibrogen

Armistice Capital
Susquehanna International
Vanguard Group
Acadian Asset Management
BlackRock
Marshall Wace
PRIMECAP Management Company
Geode Capital Management
Two Sigma Investments
HighTower Advisors
Renaissance Technologies
Citadel Advisors
State Street Corporation
Squarepoint Ops
Wolverine Trading

View all funds holding Fibrogen